{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:55:10Z","timestamp":1774266910104,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["L'Enc\u00e9phale"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.encep.2007.11.007","type":"journal-article","created":{"date-parts":[[2008,4,3]],"date-time":"2008-04-03T12:12:53Z","timestamp":1207224773000},"page":"618-624","source":"Crossref","is-referenced-by-count":38,"title":["Antipsychotiques atypiques et syndrome malin des neuroleptiques\u00a0: br\u00e8ve revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"34","author":[{"given":"S.","family":"Khaldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Kornreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Choubani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gourevitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.encep.2007.11.007_bib1","first-page":"63","article-title":"Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia","volume":"98","author":"Aboraya","year":"2002","journal-title":"W V Med J"},{"key":"10.1016\/j.encep.2007.11.007_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1081\/CLT-200035214","article-title":"Neuroleptic malignant syndrome in a child treated with an atypical antipsychotic","volume":"42","author":"Abu-Kishk","year":"2004","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.encep.2007.11.007_bib3","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/0006-3223(87)90010-2","article-title":"Neuroleptic malignant syndrome: review and analysis of 115 cases","volume":"22","author":"Addonizio","year":"1987","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib4","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.v65n0403","article-title":"Neuroleptic malignant syndrome and atypical antipsychotics drugs","volume":"65","author":"Ananth","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0033-3182(99)71247-8","article-title":"Neuroleptic malignant syndrome associated with olanzapine therapy","volume":"40","author":"Apple","year":"1999","journal-title":"Psychosomatics"},{"key":"10.1016\/j.encep.2007.11.007_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/hup.250","article-title":"Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia","volume":"16","author":"Arnaout","year":"2001","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.encep.2007.11.007_bib7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1177\/070674370204700917","article-title":"A case of neuroleptic malignant syndrom with clozapine and risperidone","volume":"47","author":"Beauchemin","year":"2002","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1592\/phco.23.2.255.32091","article-title":"Neuroleptic malignant syndrome in an adolescent receiving olanzapine\u2013lithium combination therapy","volume":"23","author":"Berry","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.encep.2007.11.007_bib9","series-title":"Textbook of psychopharmacology","article-title":"Treatment of schizophrenia","author":"Buckley","year":"1995"},{"key":"10.1016\/j.encep.2007.11.007_bib10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3109\/00048679609062668","article-title":"Neuroleptic malignant syndrome and clozapine monotherapy","volume":"30","author":"Chatterton","year":"1996","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib11","first-page":"105","article-title":"Clozapine-induced neuroleptic malignant syndrome","volume":"52","author":"DasGupta","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib12","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1176\/ajp.152.8.1233b","article-title":"Two cases of risperidone-induced neuroleptic malignant syndrome","volume":"152","author":"Dave","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib13","first-page":"145","article-title":"Un neuroleptique majeur non ph\u00e9nothiazine et non r\u00e9serpine, l\u2019halop\u00e9ridol dans le traitement des psychoses","volume":"118","author":"Delay","year":"1960","journal-title":"Ann Med Psychol"},{"key":"10.1016\/j.encep.2007.11.007_bib14","unstructured":"Diagnostic and stastical manuel of mental disorders. 4th ed. American psychiatric association. (Washington DC, 1994). Traduction fran\u00e7aise par J-D Guelfi, et al. Paris: Masson; 1996."},{"key":"10.1016\/j.encep.2007.11.007_bib15","first-page":"1424","article-title":"Neuroleptic malignant syndrome after treatment with olanzapine","volume":"161","author":"Emborg","year":"1999","journal-title":"Ugeskr Laeg"},{"key":"10.1016\/j.encep.2007.11.007_bib16","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1345\/aph.18151","article-title":"Neuroleptic maligant syndrome associated with olanzapine","volume":"32","author":"Filice","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.encep.2007.11.007_bib17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/106002809603000308","article-title":"Suspected neuroleptic malignant syndrome in a patient receiving clozapine","volume":"30","author":"Ganelin","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.encep.2007.11.007_bib18","first-page":"239","article-title":"Neuroleptic malignant syndrome associated with olanzapine","volume":"113","author":"Garcia Lopez","year":"1999","journal-title":"Med Clin"},{"key":"10.1016\/j.encep.2007.11.007_bib19","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1176\/ajp.156.11.1836","article-title":"Recurrence of neuroleptic malignant syndrome with olanzapine","volume":"156","author":"Gheorghiu","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib20","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1176\/ajp.155.8.1113","article-title":"Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique","volume":"155","author":"Hassan","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib21","first-page":"49","article-title":"Neuroleptic malignant syndrome due to olanzapine","volume":"35","author":"Hall","year":"2001","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.encep.2007.11.007_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/cap.2004.14.481","article-title":"Neuroleptic malignant syndrome in an adolescent after brief exposure to olanzapine","volume":"14","author":"Hanft","year":"2004","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.encep.2007.11.007_bib23","first-page":"4","article-title":"Neuroleptic malignant syndrome and low-dose onalzapine","volume":"160","author":"Hester","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib24","first-page":"522","article-title":"Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge","volume":"24","author":"Huang","year":"2001","journal-title":"Chang Gung Med J"},{"key":"10.1016\/j.encep.2007.11.007_bib25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.3109\/00048679809073880","article-title":"Neuroleptic malignant syndrome associated with olanzapine","volume":"32","author":"Johnson","year":"1998","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1055\/s-2005-873157","article-title":"Necrotizing enterocolitis after antipsychotic treatment involving clozapine and review of severe digestive complications. A case report","volume":"38","author":"Khaldi","year":"2005","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/s-2003-40681","article-title":"Life threatening neuroleptic malignant syndrome due to olanzapine","volume":"30","author":"Kopf","year":"2003","journal-title":"Psychiatr Prax"},{"key":"10.1016\/j.encep.2007.11.007_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0278-5846(01)00257-3","article-title":"Toxic interaction between risperidone and clozapine: a case report","volume":"26","author":"Kontaxakis","year":"2002","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib29","series-title":"The neuroleptic malignant syndrom and related conditions","author":"Lazarus","year":"1989"},{"key":"10.1016\/j.encep.2007.11.007_bib30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/hup.470090410","article-title":"Neuroleptic malignant syndrome associated with the use of risperidone, an atypical antipsychotic agent","volume":"9","author":"Lee","year":"1994","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.encep.2007.11.007_bib31","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/S0149-2918(04)90182-8","article-title":"Neuroleptic malignant syndrome associated with ziprasidone in an adolescent","volume":"26","author":"Leibold","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.encep.2007.11.007_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00004714-199910000-00016","article-title":"Neuroleptic malignant syndrome after the initiation of olanzapine","volume":"19","author":"Levenson","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2007.11.007_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00004714-199604000-00015","article-title":"Neuroleptic malignant syndrome with risperidone","volume":"16","author":"Levin","year":"1996","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2007.11.007_bib34","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1176\/ajp.156.7.1115a","article-title":"Olanzapine induced neuroleptic malignant syndrome with mental retardation","volume":"156","author":"Margolese","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1176\/appi.ajp.162.4.812","article-title":"Neuroleptic malignant syndrome induced by quetiapine and fluvoxamine","volume":"162","author":"Matsumoto","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib36","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/070674379604100112","article-title":"Risperidone-induced neuroleptic malignant syndrome: a case report and review","volume":"41","author":"Meterissian","year":"1996","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib37","first-page":"99","article-title":"A case of clozapine-induced neuroleptic malignant syndrome","volume":"52","author":"Miller","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib38","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/S0140-6736(88)90986-5","article-title":"Neuroleptic malignant syndrome after clozapine plus carbamazepine","volume":"2","author":"Muller","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.encep.2007.11.007_bib39","first-page":"534","article-title":"Risperidone and neuroleptic malignant syndrome: a case report","volume":"56","author":"Najara","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib40","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archpsyc.1997.01830220079011","article-title":"Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate","volume":"54","author":"Nyberg","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib41","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1192\/bjp.158.6.850","article-title":"Is the predisposition to neuroleptic malignant syndrome genetically transmitted?","volume":"158","author":"Otani","year":"1991","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib42","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00005053-198608000-00010","article-title":"Apparent neuroleptic malignant syndrome with clozapine and lithium","volume":"174","author":"Pope","year":"1986","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.encep.2007.11.007_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3109\/10401239309148920","article-title":"Neuroleptic malignant syndrome and clozapine","volume":"5","author":"Reddig","year":"1993","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib44","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1089\/cap.2000.10.327","article-title":"Case study. Risperidone-induced neuroleptic malignant syndrome in an adolescent","volume":"10","author":"Robb","year":"2000","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.encep.2007.11.007_bib45","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00004714-199510000-00010","article-title":"Clozapine-induced neuroleptic malignant syndrome: review and report of new cases","volume":"15","author":"Sachdev","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2007.11.007_bib46","first-page":"18","article-title":"Mortality from neuroleptic malignant syndrome","volume":"50","author":"Shalev","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib47","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1177\/106002809603000713","article-title":"Risperidone-induced neuroleptic malignant syndrome","volume":"30","author":"Sharma","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.encep.2007.11.007_bib48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/00004714-200012000-00021","article-title":"Neuropletic malignant syndrome and olanzapine","volume":"20","author":"Sierra-Biddle","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.encep.2007.11.007_bib49","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1176\/appi.ajp.159.1.149","article-title":"Neuroleptic malignant syndrome and quetiapine","volume":"159","author":"Sing","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib50","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/070674370204700826","article-title":"Quetiapine and neuroleptic malignant syndrome","volume":"47","author":"Solomons","year":"2002","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0736-4679(00)00263-8","article-title":"Neuroleptic malignant syndrome with olanzapine therapy: a case report","volume":"19","author":"Stanfield","year":"2000","journal-title":"J Emerg Med"},{"key":"10.1016\/j.encep.2007.11.007_bib52","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1176\/appi.ajp.158.10.1714","article-title":"Association of the TaqI A polymorphism of the dopamine D2 receptor gene with predisposition to neuroleptic malignant syndrome","volume":"158","author":"Suzuki","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib53","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jama.1996.03530300030031","article-title":"Risperidone and neuroleptic malignant syndrome","volume":"275","author":"Tarsy","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.encep.2007.11.007_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/10401239509149033","article-title":"Neuroleptic malignant syndrome associated with clozapine treatment","volume":"7","author":"Tsai","year":"1995","journal-title":"Ann Clin Psychiatry"},{"key":"10.1016\/j.encep.2007.11.007_bib55","first-page":"55","article-title":"Neuroleptic malignant syndrome with clozapine monotherapy and benign hyperthermia after resolving neuroleptic malignant syndrome with clozapine. Two case reports","volume":"62","author":"Vetter","year":"1991","journal-title":"Nervenarzt"},{"key":"10.1016\/j.encep.2007.11.007_bib56","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0140-6736(94)90542-8","article-title":"Risperidone-induced neuroleptic malignant syndrome","volume":"344","author":"Webster","year":"1994","journal-title":"Lancet"}],"container-title":["L'Enc\u00e9phale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700608000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0013700608000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T12:08:08Z","timestamp":1684325288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0013700608000110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0013700608000110"],"URL":"https:\/\/doi.org\/10.1016\/j.encep.2007.11.007","relation":{},"ISSN":["0013-7006"],"issn-type":[{"value":"0013-7006","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}